How should a titration experiment be performed after newly purchasing anti-human CD19-PE flow cytometry antibody?

Fixing with 1% paraformaldehyde and running the samples the next day is feasible. PE is a conventional small-molecule fluorochrome and is relatively tolerant to fixation, so the population distribution usually does not change much. However, fixation will alter FSC/SSC, potentially causing cells to shrink slightly and debris to increase somewhat. It is recommended that after staining and washing, one portion be run fresh as a baseline, while another portion be fixed and stored at 4°C protected from light, then measured the next day to compare the CD19+ positive percentage and MFI. If the PE fluorescence does not decrease significantly and the CD19+ population remains clearly distinguishable, fixation is acceptable; if the decrease is substantial, it is best to run the samples the same day or switch to a shorter fixation time.

For titration of anti-human CD19-PE, it is recommended to start at a concentration of 10 μg/mL. Commercial PE antibodies are commonly supplied as 0.2–1 mg/mL stock solutions, which should first be diluted to an appropriate working solution. Eight concentrations can be set: 10, 5, 2.5, 1.25, 0.625, 0.312, 0.156, and 0.078 μg/mL, using a 100 μL system to stain 5×10^5 PBMCs. CD19 is strongly expressed on B cells and is usually saturated at 0.1–0.5 μg/mL, but this must be determined empirically. An additional 0 μg/mL tube should be set up as the background tube.

Each tube of 5×10^5 PBMC is fully sufficient for titration, but if 8 concentrations plus replicate wells are set up, the total cell requirement is approximately 8-16×10^6 PBMC. When clinical samples are limited, single wells can be run first, with the focus on operational consistency; if sufficient samples are available, set up 2 replicate wells near the expected optimal concentration to confirm reproducibility. Replicate wells are not essential for titration; they are more for verifying operational error. Note that the cell number per tube should be kept as consistent as possible, preferably from the same PBMC batch after mixing and aliquoting, to avoid interference from inter-donor variability on the concentration effect.

Use PBS containing 0.5% BSA as the diluent, prepare fresh immediately before use, and avoid storing the diluted antibody for extended periods. A 96-well U-bottom plate is recommended, with a 50-100 μL system per well; 5×10^5 cells are sufficient. After adding the antibody, incubate at 4°C in the dark for 30 min, then wash twice with 200 μL washing buffer. Dilution must be precise, especially at low concentration points; it is recommended to first prepare a 2× concentration and then mix it with the cell suspension in equal volume to reduce pipetting error. For titration experiments, at least 1 tube per concentration, and duplicate can be performed for intermediate concentrations.

Don't rely solely on the positive percentage when interpreting titration results. It is recommended to calculate the signal-to-noise ratio: CD19+ B cell MFI divided by CD19- T cell MFI, or use the staining index (positive MFI - negative MFI) / (2 × negative SD). Plot a concentration-signal-to-noise ratio curve and select the lowest concentration that reaches the plateau phase and occurs before background begins to rise, which is typically the optimal working concentration. Record this concentration and the antibody lot, and use this dilution for subsequent batch experiments. Be careful to distinguish between B cells and plasmablasts/plasma cells with weak CD19 expression, and ensure the lymphocyte population is gated consistently.